Strategic Partnerships MyOme has demonstrated a pattern of collaboration and platform expansion through partnerships with Natera and Thatch Health, signaling openness to ecosystem-based distribution and co-developed solutions that can extend reach into clinics, marketplaces, and specialty care networks.

Proactive Health Network The launch of the Proactive Health Network indicates a shift toward proactive, personalized health management at scale. This creates opportunities to offer genomic risk profiling, chronic disease prevention programs, and concierge/elite clinic collaborations to capture high-value, prevention-focused client segments.

Board & Leadership Recent additions to the board including Sam Roosz and Dr. Ravi Thadhani suggest a governance shift toward strategic growth and clinical credibility, which can be leveraged to engage enterprise customers seeking trusted genomics partners with strong governance and clinical leadership.

Product Showcase Zenith powered by MyOme and long-read methylation analysis showcased at ACMG 2026 highlight innovation in diagnostics and actionable reports. This affords sales angles around enhanced diagnostic capability, rare disease insights, and expanded payer-coverage conversations with health systems.

Market Positioning With a mid-size headcount and revenue in the tens of millions, MyOme sits between startup agility and mid-market credibility, presenting a compelling case to target mid-to-large clinics, integrated health systems, and genetics-focused concierge networks seeking scalable whole-genome analysis and PRS-based risk modeling.